Plaquenil is used to treat or prevent malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia. Does plaquenil cause you to gain weight Chloroquine malaria in wwii Chloroquine and hydroxychloroquine have the same indications and usage, although the dosage regimens are different. Head-to-head comparisons suggest similar responses with equivalent doses, but greater retinal toxicity with chloroquine 2. In dermatology, antimalarial drugs, such as chloroquine, are regarded as appropriate treatments for Hydroxychloroquine is licensed for the treatment of malaria, and is one of several antimalarial drugs that have anti-inflammatory effects useful in other diseases. In primary care physicians and other non-dermatology specialists, the most frequently prescribed medications for lupus were prednisone and hydroxychloroquine; whereas, hydroxychloroquine and triamcinolone were the top two medications preferred by dermatologists. Plaquenil is also an antirheumatic medicine and is used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus. This medicine is not effective against all strains of malaria. Hydroxychloroquine dermatology Hydroxychloroquine DermNet NZ, HYDROXYCHLOROQUINE Plaquenil skutki uboczneHydroxychloroquine urticaria angioedema Hydroxychloroquine Plaquenil was approved by the FDA in 1955 for treatment of malaria, and is structurally related to the other antimalarial chloroquine. However, hydroxychloroquine and chloroquine have some different uses in treating systemic and dermatologic conditions. Hydroxychloroquine - American Osteopathic College of.. Hydroxychloroquine Therapeutic Cheat Sheet - Next Steps in.. Updated recommendations on the use of hydroxychloroquine.. Background Hydroxychloroquine sulfate and other antimalarial drugs have been used successfully as adjunctive therapy for patients with cutaneous lesions of dermatomyositis over the past 20 years. An increased incidence of cutaneous reactions to hydroxychloroquine has been postulated to occur. Hydroxychloroquine is an age-old drug whose use as an immunomodulatory agent with a low side-effect profile continues to expand. We present a review of this drug including recently updated prescribing recommendations and a summary of its clinical application in dermatology. Hydroxychloroquine has unique immunomodulatory properties and an attractive adverse effect profile. Over the past 10 years, research has led to significant updates in clinical recommendations concerning the optimal use of hydroxychloroquine and monitoring of patients taking it.